# 动脉切除系统市场

> 动脉切除系统市场研究报告按手术类型（外周动脉切除、冠状动脉切除、脑动脉切除）、按设备类型（旋转动脉切除设备、定向动脉切除设备、轨道动脉切除设备）、按最终用户（医院、专科诊所、门诊手术中心）、按应用（冠状动脉疾病、外周动脉疾病、脑血管疾病）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.16%
- **2024:** $ 1.76 Billion
- **2025:** $ 1.85 Billion
- **2035:** $ 3.06 Billion
- **Key Players:** Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), Cardiovascular Systems (US), Spectranetics (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Philips (NL), Johnson & Johnson (US)

**Report ID:** MRFR/HC/32419-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/atherectomy-system-market-34266

---

## Market Summary

## **Global Atherectomy System Market Overview**

As per MRFR analysis, the Atherectomy System Market Size was estimated at 1.76 (USD Billion) in 2024. The Atherectomy System Market Industry is expected to grow from 1.85 (USD Billion) in 2025 to 2.90 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.16% during the forecast period (2025 - 2034).

**Key Atherectomy System Market Trends Highlighted**

The Atherectomy System Market is experiencing notable growth driven by an increase in the prevalence of cardiovascular diseases and the rising aging population. The demand for minimally invasive procedures is pushing healthcare providers to adopt advanced technologies. Additionally, the development of innovative atherectomy devices that improve patient outcomes has been instrumental in expanding the market. As healthcare systems globally strive to reduce costs while increasing the quality of care, atherectomy systems that enhance procedural efficacy are becoming essential tools for cardiovascular interventions. There are several opportunities for growth within the atherectomy system sector.

As awareness about cardiovascular health rises, healthcare providers are seeking newer solutions for treatment. This trend creates potential for research and development in next-generation atherectomy devices that can cater to a broader range of vascular conditions. Emerging markets present an opportunity for manufacturers to expand their reach as they enhance their healthcare infrastructure. Partnerships between companies and healthcare facilities can lead to better access to advanced treatments, thus capturing a larger market share. In recent times, there has been a noticeable shift toward the integration of digital technology into atherectomy systems.

This includes the use of imaging systems and real-time data analytics to assist physicians during procedures. Additionally, training programs for healthcare professionals regarding the latest technologies in atherectomy have become more prevalent. Telehealth advancements are also reshaping the way post-operative care is managed, allowing for better patient monitoring and follow-up. Overall, these market trends indicate a robust landscape for the global atherectomy system market, with ongoing advancements poised further to enhance patient care and operational efficiency in cardiovascular treatments.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Atherectomy System Market Drivers**

**Increasing Prevalence of Cardiovascular Diseases**

The Atherectomy System Market is significantly driven by the rising prevalence of cardiovascular diseases worldwide. The growing incidence of conditions such as coronary artery disease, peripheral artery disease, and other heart-related ailments necessitates advanced therapeutic options, leading to a higher demand for atherectomy systems. As more individuals are diagnosed with these conditions, the healthcare industry must adapt to the increasing need for minimally invasive procedures that can effectively restore blood flow and improve patient outcomes.

Atherectomy systems offer a promising solution by allowing physicians to remove plaque build-up from blood vessels without extensive surgical procedures. This demand is particularly high in aging populations, where cardiovascular health is a primary concern. Moreover, awareness campaigns and health initiatives aimed at combating cardiovascular diseases further catalyze the growth of the Atherectomy System Market industry. Healthcare providers are increasingly investing in atherectomy systems as part of their cardiovascular treatment protocols, ensuring patient access to cutting-edge technologies that improve survival rates and quality of life.

Consequently, as the global population ages and lifestyle-related health issues rise, the demand for atherectomy systems is expected to grow robustly, making it a critical driver of market expansion in the coming years.

**Technological Advancements in Atherectomy Systems**

Technological advancements play a pivotal role in the growth of the Atherectomy System Market industry. Innovations in device design, materials, and technology have led to the development of more efficient and effective atherectomy systems. These advancements include improvements in safety features, precision, and ease of use for healthcare professionals, which in turn significantly enhance patient outcomes. As technology continues to evolve, manufacturers that invest in research and development are likely to dominate the market landscape, driving competitive growth and offering increasingly sophisticated solutions for the management of cardiovascular diseases.

**Rising Demand for Minimally Invasive Procedures**

The shift towards minimally invasive surgical approaches is a crucial driver in the Global Atherectomy System Market. Patients and healthcare providers are increasingly favoring less invasive options due to the associated benefits, such as reduced recovery times, lower risk of complications, and minimal scarring. Atherectomy procedures align with this demand, offering effective treatment for arterial blockages while minimizing the physical impact on patients.As awareness about the advantages of minimally invasive techniques grows, healthcare institutions are expected to incorporate atherectomy systems into their standard practices, further propelling market growth.

## **Atherectomy System Market Segment Insights**

### Atherectomy System Market Procedure Type Insights  

The Atherectomy System Market is showing promising growth across various procedure types, with a substantial focus on different applications. As of 2023, the market is valued at 1.59 USD Billion, indicating a healthy demand for innovative atherectomy systems.

Among the different procedure types, Peripheral Atherectomy held a significant position, valued at 0.65 USD Billion in 2023 and expected to reach 1.05 USD Billion by 2032, making it a key player in the market. This dominance is attributed to the rising prevalence of peripheral artery diseases, which necessitate effective treatment options.

Similarly, Coronary Atherectomy was also a major contributor to the Global Atherectomy System Market, with a valuation of 0.75 USD Billion in 2023, anticipated to grow to 1.3 USD Billion by 2032. The need for treating coronary artery disease effectively fuels the growth of this segment, reflecting the pressing demand for advanced treatment technologies.

On the other hand, Cerebral Atherectomy, while critical, has a comparatively lower valuation of 0.19 USD Billion in 2023, with a slight decline to 0.15 USD Billion by 2032, indicating unique challenges in its broader adoption.This difference may stem from the complexities associated with cerebral procedures, making them less common compared to peripheral and coronary procedures. The Atherectomy System Market data reveals that together, these procedure types reflect the current landscape and future potential of atherectomy systems, driven by ongoing advancements in medical technology and the need for more efficient treatment options. 

The market trends indicate a shift towards less invasive procedures and a growing preference for outpatient solutions, which further impacts the segmentation.Additionally, the regulatory environment and healthcare expenditure in various regions also play vital roles in shaping these segments. The overall market growth is supported by the increasing aging population and a rise in lifestyle-related health issues, creating opportunities for enhancements in the Atherectomy System Market industry.

While Peripheral and Coronary Atherectomy is on the rise, the challenges faced by Cerebral Atherectomy highlight the varying dynamics and considerations in the Atherectomy System Market segmentation. The diverse factors influencing these segments reflect a comprehensive and evolving market scenario poised for continued growth in the coming years.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

### Atherectomy System Market Device Type Insights  

The Global Atherectomy System Market, valued at 1.59 billion USD in 2023, demonstrates significant growth potential within the Device Type segment. This segment comprises various innovative devices, crucial for treating cardiovascular conditions by removing arterial plaque. Rotational Atherectomy Devices are essential for their ability to effectively treat calcified lesions, while Directional Atherectomy Devices are valuable for selectively targeting and excising blockages. 

Orbital Atherectomy Devices play a pivotal role in advancing minimally invasive procedures, helping to reduce recovery time for patients.This diverse range of devices contributes to the market's expansion, supported by the increasing prevalence of coronary artery diseases and technological advancements. The rising awareness of cardiovascular health and the growing elderly population drive market growth.

However, challenges such as high costs associated with these devices and the need for skilled professionals to operate them may hinder wider adoption. Nevertheless, opportunities persist in developing regions where healthcare infrastructure is improving and demand for effective cardiovascular treatments is rising, creating a favorable landscape for the Global Atherectomy System Market.

### Atherectomy System Market End User Insights  

The Atherectomy System Market is expected to witness significant evolution across various end users, including hospitals, specialty clinics, and ambulatory surgical centers. In 2023, the complete market's valuation was observed at 1.59 USD billion, illustrating a growing demand for these systems.

Hospitals constitute a major portion of the end-user landscape, primarily due to their extensive patient base and advanced healthcare facilities capable of conducting complex procedures. Specialty clinics have also gained traction, offering targeted services and patient-centric care, thereby enhancing the access and effectiveness of atherectomy procedures.

Furthermore, ambulatory surgical centers represent a noteworthy segment due to their affordability and convenience for outpatient procedures, making them increasingly popular among patients. As these segments continue to expand, the Atherectomy System Market data indicates a favorable growth trajectory, driven by factors such as technological advancements, rising prevalence of cardiovascular diseases, and increasing awareness regarding minimally invasive treatments. However, challenges like regulatory hurdles and high costs of devices may impact the overall market dynamics.The Atherectomy System Market statistics reflect an evolving landscape that showcases the importance of these varied end users in meeting healthcare demands.

**Atherectomy System Market Application Insights  **

The Global Atherectomy System Market, valued at 1.59 billion in 2023, showcases a diverse range of applications catering to various cardiovascular diseases. This market segmentation includes critical areas such as Coronary Artery Disease, Peripheral Arterial Disease, and Cerebrovascular Disease. Coronary Artery Disease remains a key application within this segment, reflecting the rising incidence of coronary interventions and the growing need for effective treatment options. Concurrently, Peripheral Arterial Disease is increasingly gaining prominence due to its prevalence in aging populations and those with comorbidities, making it a significant contributor to market growth.

Additionally, Cerebrovascular Disease plays a crucial role, as advancements in atherectomy technology offer improved patient outcomes through minimally invasive procedures. These applications collectively drive innovation and research in the Atherectomy System Market industry, addressing pressing health challenges while capitalizing on opportunities for expansion.

The market trends indicate a shift towards more advanced and specialized treatment devices that cater to the distinct needs of each application, facilitating significant improvements in both procedural efficacy and patient recovery.

### Atherectomy System Market Regional Insights  

The Atherectomy System Market revenue in 2023 stands at approximately 1.59 USD Billion, reflecting a solid interest in cardiovascular treatments globally. North America led the regional segmentation with a valuation of 0.7 USD Billion in 2023 and is expected to dominate the market by reaching 1.1 USD Billion in 2032, driven by advanced healthcare infrastructure and high prevalence of cardiovascular diseases.

Europe followed closely, valued at 0.4 USD Billion in 2023 and projected to grow to 0.7 USD Billion by 2032, showcasing significant advancements in medical technology.Meanwhile, the APAC region, valued at 0.3 USD Billion in 2023, is gradually gaining ground with a forecasted growth of 0.5 USD Billion as healthcare access improves and awareness of cardiovascular conditions rises.

South America and the MEA regions represent the smaller segments of this market, with valuations of 0.1 USD Billion and 0.02 USD Billion in 2023, respectively, but they are expanding slowly due to increasing healthcare investments and the demand for better cardiovascular treatments.

The overall market growth is driven by rising incidences of peripheral arterial diseases and technological developments in atherectomy systems, presenting opportunities across all regions.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

## Atherectomy System Market Key Players and Competitive Insights

The Atherectomy System Market has been witnessing increasing competition driven by advancements in technology and a growing demand for minimally invasive procedures. Atherectomy, a procedure used to remove atherosclerotic plaque from arteries, is becoming more prominent due to its ability to improve vascular health and reduce complications associated with traditional surgical methods. The market is characterized by various players striving to deliver innovative products that meet regulatory standards while addressing the needs of patients and healthcare providers.

As medical professionals continue to seek effective solutions for cardiovascular diseases, companies are focusing on research and development to enhance performance and safety in atherectomy devices, thereby shaping the competitive landscape of the market.

Smith and Nephew have carved a notable presence in the Atherectomy System Market thanks to their commitment to innovation and quality in healthcare solutions. The company boasts a strong portfolio of technologically advanced products that address the evolving needs of clinicians and hospitals. With a robust research and development framework, Smith and Nephew continuously enhance its offering by integrating cutting-edge technology, such as advanced imaging and lesion preparation capabilities, into its atherectomy systems. This allows the company to not only offer superior efficacy in plaque removal but also improve procedural safety for patients.

Additionally, the global reach of Smith and Nephew and its established relationships with healthcare professionals facilitate wide acceptance and trust, bolstering its competitive position in this specialized area of the market.B. Braun Melsungen has emerged as an influential player in the Global Atherectomy System Market, well-known for its focus on high-quality medical devices and innovative approaches to patient care. The company exhibits a strong emphasis on creating products that enhance the efficiency of minimally invasive cardiovascular procedures. B.

Braun Melsungen leverages its extensive experience in the healthcare sector to produce reliable and effective atherectomy systems that cater to the specific requirements of varying medical environments. 

Through strategic collaborations and partnerships, the company further expands its market presence, ensuring that its advanced solutions are accessible to a broad range of healthcare providers. Additionally, B. Braun Melsungen's dedication to educational programs helps to advance the understanding and application of its technologies, further fortifying its standing in the competitive landscape of the atherectomy market.

### Key Companies in the Atherectomy System Market Include

### Atherectomy System Market Industry Developments

- **Q2 2024: Cardiovascular Systems, Inc. Announces FDA Clearance of Diamondback 360® Coronary Orbital Atherectomy System for New Indication** Cardiovascular Systems, Inc. received FDA clearance for an expanded indication of its Diamondback 360® Coronary Orbital Atherectomy System, allowing use in additional patient populations with coronary artery disease.
- **Q2 2024: Philips launches new Laser Atherectomy System in the U.S.** Philips announced the commercial launch of its next-generation laser atherectomy system in the United States, designed to improve the treatment of peripheral artery disease with enhanced precision and safety features.
- **Q3 2024: Avinger Announces FDA 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System** Avinger, Inc. received FDA 510(k) clearance for its Pantheris LV, an image-guided atherectomy system intended for the treatment of larger vessels in patients with peripheral artery disease.
- **Q2 2024: Medtronic Receives CE Mark for TurboHawk™ Plus Directional Atherectomy System** Medtronic announced it has received CE Mark approval for its TurboHawk™ Plus Directional Atherectomy System, enabling commercialization in the European Union for the treatment of peripheral artery disease.
- **Q1 2024: Boston Scientific Completes Acquisition of Vascular Therapies, Expanding Peripheral Interventions Portfolio** Boston Scientific completed the acquisition of Vascular Therapies, a company specializing in atherectomy and vascular access technologies, to strengthen its peripheral interventions business.
- **Q2 2024: Ra Medical Systems Announces Strategic Partnership with MedAlliance for Atherectomy Device Distribution** Ra Medical Systems entered into a strategic partnership with MedAlliance to distribute its atherectomy devices in select international markets, aiming to expand global reach.
- **Q3 2024: Avinger Announces Commercial Launch of Tigereye ST Image-Guided CTO Crossing Catheter** Avinger launched its Tigereye ST, an image-guided chronic total occlusion (CTO) crossing catheter, in the U.S. market, expanding its suite of atherectomy and crossing devices.
- **Q2 2024: Cardio Flow, Inc. Receives FDA Clearance for FreedomFlow® Orbital Atherectomy System** Cardio Flow, Inc. received FDA clearance for its FreedomFlow® Orbital Atherectomy System, designed for the treatment of peripheral arterial disease in the lower extremities.
- **Q1 2024: Shockwave Medical Announces FDA Approval of Shockwave M5+ Peripheral IVL Catheter** Shockwave Medical received FDA approval for its Shockwave M5+ Peripheral IVL Catheter, which combines intravascular lithotripsy with atherectomy for the treatment of calcified peripheral artery disease.
- **Q2 2024: Medtronic Opens New Manufacturing Facility for Peripheral Vascular Devices in Galway, Ireland** Medtronic opened a new manufacturing facility in Galway, Ireland, dedicated to the production of peripheral vascular devices, including atherectomy systems, to meet growing global demand.
- **Q3 2024: Avinger Announces $15 Million Public Offering to Support Atherectomy Product Development** Avinger completed a $15 million public offering to fund the development and commercialization of its next-generation image-guided atherectomy devices.
- **Q2 2024: Philips partners with Mayo Clinic to advance atherectomy device research** Philips entered into a research partnership with Mayo Clinic to develop and clinically validate new atherectomy technologies for the treatment of complex vascular disease.

## Atherectomy System Market Segmentation Insights

## Market Drivers

### 影响市场的监管变化

动脉切除系统市场受到不断变化的医疗器械监管框架的影响。监管机构越来越关注动脉切除系统的安全性和有效性，这导致了更严格的审批流程。虽然这最初可能给制造商带来挑战，但它也确保只有高质量的产品进入市场。遵守这些法规可以增强消费者信任，并可能导致更高的采用率。此外，创新设备的快速通道的引入可能会促进新技术更快地进入市场。随着法规继续适应快速的创新步伐，动脉切除系统市场可能会看到竞争动态的变化，优先考虑合规的公司将获得战略优势。

### 动脉切除系统的技术进步

动脉切除系统市场正在经历技术进步的激增，这些进步提高了手术的有效性和安全性。激光和旋转动脉切除系统等创新正变得越来越普遍，使得动脉粥样硬化斑块的去除更加精确。这些进展不仅改善了患者的治疗效果，还缩短了恢复时间，这在一个优先考虑效率的医疗环境中至关重要。微创技术的引入预计将推动市场增长，因为它们与较低的并发症发生率相关。此外，先进成像技术的整合，如血管内超声，可能会促进更好的手术规划和执行。因此，动脉切除系统市场有望实现显著扩张，预计未来几年复合年增长率可能超过8%。

### 心血管疾病的发病率上升

动脉切除系统市场受到心血管疾病日益普遍的显著推动，心血管疾病仍然是全球发病率和死亡率的主要原因。随着人口老龄化和与生活方式相关的风险因素变得更加普遍，对有效治疗方案的需求正在上升。根据最新数据，心血管疾病占全球死亡人数的近31%，突显了对先进治疗解决方案的迫切需求。动脉切除系统旨在治疗冠状动脉的阻塞，越来越被视为管理这些疾病的重要工具。预计这一不断增长的患者群体将推动动脉切除系统市场的发展，估计市场价值在未来十年内可能达到数十亿美元。

### 增加对医疗基础设施的投资

动脉切除系统市场受益于各地区对医疗基础设施的投资增加。各国政府和私营实体认识到改善医疗设施以适应先进医疗技术的重要性。这种投资在建立配备最先进动脉切除系统的专门心血管中心方面尤为明显。增强的基础设施不仅促进了这些技术的采用，还改善了患者获得必要治疗的机会。随着医疗系统的发展以满足日益增长的患者群体的需求，动脉切除系统市场可能会经历强劲增长。预测表明，这一趋势可能导致市场扩张，与对预防性和介入性心脏病学日益关注的趋势相一致。

### 提高对心血管健康的认识和教育

动脉切除系统市场也受到对心血管健康日益增长的意识和教育的推动。公共卫生宣传和教育倡议越来越强调早期发现和治疗心血管疾病的重要性。随着患者对自身健康的了解加深，他们更有可能寻求先进的治疗选择，包括动脉切除手术。这种增强的意识正在促进对心血管护理的更积极的态度，预计将推动对动脉切除系统的需求。此外，医疗服务提供者正在投资培训项目，以确保从业人员熟悉最新的动脉切除技术。这种对教育的重视可能会提高整体护理质量，进一步支持动脉切除系统市场的增长。

## Future Outlook

动脉切除系统市场预计将在2024年至2035年间以5.16%的年均增长率增长，推动因素包括技术进步、心血管疾病增加和医疗支出上升。

**New opportunities:**

- 开发集成成像技术的先进动脉切除设备。 在新兴市场扩展，提供量身定制的产品。 与医疗服务提供者建立合作关系，提供捆绑服务套餐。

到2035年，动脉切除系统市场预计将实现显著增长和创新。

## Segment Insights

### 按程序类型：外周动脉切除术（最大）与冠状动脉切除术（增长最快）

动脉切除系统市场主要分为三种关键的手术类型：外周动脉切除、冠状动脉切除和脑动脉切除。在这三者中，外周动脉切除作为最大的细分市场，由于其在治疗外周动脉疾病中的广泛应用，捕获了大部分市场份额。相比之下，冠状动脉切除由于冠状动脉疾病的日益普遍，正迅速成为增长最快的细分市场，反映出近年来采用率和手术量的显著上升。

外周动脉切除术（主导）与冠状动脉切除术（新兴）

外周动脉切除术仍然是动脉切除系统市场的主导手术类型，主要由于其在管理外周血管疾病方面的有效性。它满足了广泛的人群，为下肢有阻塞的患者提供了显著的缓解。另一方面，冠状动脉切除术被视为一个新兴领域，其特点是技术的快速进步和对冠状动脉动脉粥样硬化病变的临床应用日益增加。该领域受益于外科医生专业技能的提升和改善的治疗效果，使其对心血管健康至关重要。这两个领域展现出独特的价值主张，满足不同患者的需求，同时影响整体市场增长。

### 按设备类型：旋转动脉粥样硬化切除设备（最大）与定向动脉粥样硬化切除设备（增长最快）

动脉切除系统市场正在经历各种设备类型之间市场份额的显著分配。旋转动脉切除设备处于领先地位，在临床应用中提供卓越的性能和可靠性。它们在治疗冠状动脉疾病中的既定使用使其成为医疗专业人员的首选。另一方面，定向动脉切除设备正在获得关注，提供在选择性斑块去除方面的独特优势，这吸引了微创手术的倡导者。虽然轨道动脉切除设备值得注意，但目前在比较中占有较小的份额，主要集中在特定类型的病变和患者人群上。

旋转动脉切除装置（主导）与轨道动脉切除装置（新兴）

旋转动脉切除装置因其在治疗各种动脉病变方面的良好疗效和可靠性，成为动脉切除系统市场的主导力量。它们利用高速旋转刀片机制有效地磨除斑块，成为许多心脏病专家的首选。相比之下，轨道动脉切除装置作为一种有价值的替代方案正在崭露头角，特别是对于复杂病变的患者。它们采用轨道机制，增强了斑块去除的精确性。尽管在市场上仍在逐步站稳脚跟，但其独特的方法可能满足特定患者的需求，为医生提供更多个性化治疗的选择。

### 按最终用户：医院（最大）与专科诊所（增长最快）

动脉切除系统市场受到其最终用户细分的显著影响，包括医院、专科诊所和门诊手术中心。医院在这一市场细分中占据主导地位，利用先进的技术和广泛的患者接入，满足需要动脉切除手术的患者。它们建立的基础设施和全面的医疗服务使其成为这些系统采用的关键参与者，从而在市场中占据最大的份额。另一方面，专科诊所正迅速成为动脉切除系统市场的重要组成部分。这些诊所强调微创手术和以患者为中心的护理，导致患者和医疗提供者之间的偏好日益增长。向门诊环境的转变以及寻求专业心血管护理的患者数量增加是推动这一增长的关键趋势。

医院（主导）与专科诊所（新兴）

在动脉切除系统市场中，医院是主要的细分市场，主要由于其丰富的资源和在综合护理框架内整合各种血管介入程序的能力。这些机构通常拥有先进的外科设施和多样化的医疗专业人员，显著增强了其进行动脉切除手术的能力。相反，专科诊所正在成为一个关键细分市场，提供专注于心血管治疗的专业服务，包括动脉切除。它们的增长受到向门诊护理趋势增加、患者对更快恢复时间的渴望以及与传统医院环境相比成本更低的推动。这些诊所将自己定位为方便的替代方案，专门满足寻求针对性治疗的患者需求。

### 按应用：冠状动脉疾病（最大）与外周动脉疾病（增长最快）

在动脉切除系统市场中，应用细分市场主要由三个关键领域驱动：冠状动脉疾病（CAD）、外周动脉疾病（PAD）和脑血管疾病（CVD）。其中，CAD占据了最大的市场份额，反映出对有效治疗方案的显著需求。另一方面，PAD正在迅速扩大其市场存在，展示了患者不断变化的需求和满足该细分市场的动脉切除技术的进步。与此同时，CVD的市场份额较小，但对整体市场动态至关重要。

冠状动脉疾病（主导）与外周动脉疾病（新兴）

冠状动脉疾病仍然是动脉切除系统领域的主要应用，因其普遍性和有效患者管理所需的关键治疗选项。该细分市场受益于医疗提供者的长期熟悉度和与动脉切除系统相关的确立疗效。相反，外周动脉疾病正成为一个重要的增长领域，受到对该病症认识的提高、诊断技术的改善以及日益增长的老龄化人口的推动。随着市场的发展，动脉切除技术的创新正在改善外周动脉疾病的治疗效果，使其成为未来值得关注的细分市场。

## Regional Market Share Analysis

### 北美：创新的市场领导者

北美是动脉切除系统最大的市场，占全球市场份额的约45%。该地区的增长受到心血管疾病发病率上升、医疗技术进步和支持性监管框架的推动。对微创手术的需求也在上升，进一步推动市场增长。像FDA这样的监管机构简化了审批流程，增强了市场动态。美国是该地区的领先国家，拥有波士顿科学、美敦力和雅培等主要企业。竞争格局以持续创新和关键参与者之间的战略合作为特征。先进的医疗基础设施和高额的医疗支出进一步支持了北美动脉切除系统的增长。公司专注于研发以推出新产品，确保市场环境的稳健。

### 欧洲：具有潜力的新兴市场

欧洲的动脉切除系统市场正在经历显著增长，约占全球市场份额的30%。心血管疾病发病率的上升，加上老龄化人口，推动了对先进治疗选择的需求。欧洲的监管机构也在促进创新医疗设备的采用，这预计将进一步增强市场增长。德国和英国等国在市场中处于领先地位，得益于有利的报销政策。德国作为欧洲最大的市场，拥有B. Braun Melsungen AG和飞利浦等主要企业。竞争格局正在演变，公司专注于产品创新和战略合作，以增强市场地位。欧洲市场的特点是成熟企业与新兴公司的混合，促进了动态和竞争的环境。改善患者结果的重视推动了动脉切除系统新技术的发展。

### 亚太地区：快速增长的市场

亚太地区正在迅速崛起为动脉切除系统的重要市场，约占全球市场份额的20%。增长受到医疗支出上升、对心血管疾病的认识提高和老年人口增长的推动。日本和中国等国在市场中处于领先地位，政府倡导改善医疗基础设施和获取先进医疗技术。监管支持也在增强市场动态。日本是该地区最大的市场，拥有Terumo Corporation和雅培等主要企业。竞争格局以本地和国际公司混合为特征，专注于创新和产品开发。微创手术的日益普及进一步推动了该地区对动脉切除系统的需求。公司正在投资研发，以满足人口日益增长的需求，确保在市场中的竞争优势。

### 中东和非洲：新兴市场机会

中东和非洲地区在动脉切除系统市场中逐渐崭露头角，约占全球市场份额的5%。增长受到医疗投资增加、心血管疾病发病率上升和对先进医疗技术关注度提高的推动。南非和阿联酋等国在市场中处于领先地位，得益于政府倡导改善医疗基础设施和获取创新治疗。南非是该地区最大的市场，主要企业的存在不断增长，并与国际公司增加合作。竞争格局正在演变，专注于改善患者结果和扩大对先进医疗设备的获取。该地区呈现出显著的增长机会，医疗提供者越来越多地采用创新解决方案，以应对日益增加的心血管疾病负担。公司专注于战略合作，以增强市场存在感并推动增长。

## Competitive Benchmarking

动脉切除系统市场目前的特点是动态竞争格局，受到技术进步和心血管疾病日益普遍的推动。波士顿科学（美国）、美敦力（美国）和雅培实验室（美国）等主要参与者战略性地定位，以利用创新并扩大其市场存在。波士顿科学（美国）专注于通过持续创新来增强其产品组合，而美敦力（美国）则强调战略合作伙伴关系，以增强其技术能力。雅培实验室（美国）积极追求区域扩张，特别是在新兴市场，这共同塑造了一个越来越依赖创新和战略合作的竞争环境。

市场结构似乎适度分散，多个参与者争夺市场份额。主要商业策略包括本地化制造以降低成本和优化供应链，这在维持竞争定价方面至关重要。这些主要参与者的集体影响力促进了一个竞争氛围，在这里，灵活性和对市场需求的响应至关重要。这种分散化使得小众参与者能够出现，可能会扰乱既定的市场动态。

2025年8月，波士顿科学（美国）宣布推出其最新的动脉切除设备，该设备集成了先进的成像技术，以增强手术结果。这一战略举措具有重要意义，因为它不仅强化了波士顿科学对创新的承诺，还使公司能够通过满足对心血管干预精确度日益增长的需求来获取更大的市场份额。

2025年9月，美敦力（美国）与一家领先的远程医疗提供商达成合作，将远程监测能力整合到其动脉切除系统中。这一合作表明了向数字健康解决方案的更广泛趋势，表明美敦力希望通过技术提升患者结果，从而巩固其在市场中的竞争优势。

2025年7月，雅培实验室（美国）在亚洲扩大了其制造能力，旨在满足该地区对动脉切除系统日益增长的需求。这一战略扩张不仅提高了雅培的供应链效率，还使公司能够迅速响应市场需求，反映出对区域市场动态的积极应对。

截至2025年10月，动脉切除系统市场的当前竞争趋势越来越多地由数字化、可持续性和人工智能的整合所定义。战略联盟变得越来越普遍，因为公司认识到合作在推动创新中的价值。展望未来，竞争差异化可能会从传统的基于价格的竞争演变为对技术进步、创新解决方案和可靠供应链的关注，强调在快速变化的市场中适应能力的重要性。

## Recent News & Developments

- **2024年第二季度：心血管系统公司宣布获得FDA对Diamondback 360® 冠状动脉轨道切除系统市场的新适应症的批准** 心血管系统公司获得FDA批准，扩展其Diamondback 360® 冠状动脉轨道切除系统市场的适应症，允许在更多冠状动脉疾病患者中使用。
- **2024年第二季度：飞利浦在美国推出新激光切除系统市场** 飞利浦宣布在美国商业推出其下一代激光切除系统，旨在通过增强的精确度和安全性特征改善外周动脉疾病的治疗。
- **2024年第三季度：Avinger宣布获得FDA 510(k)批准，推出Pantheris LV影像引导切除系统市场** Avinger公司获得FDA 510(k)批准，推出其Pantheris LV影像引导切除系统，旨在治疗外周动脉疾病患者的大血管。
- **2024年第二季度：美敦力获得TurboHawk™ Plus方向性切除系统市场的CE标志** 美敦力宣布获得TurboHawk™ Plus方向性切除系统市场的CE标志批准，使其在欧盟的商业化成为可能，用于治疗外周动脉疾病。
- **2024年第一季度：波士顿科学完成对血管疗法公司的收购，扩展外周介入产品组合** 波士顿科学完成对专注于切除和血管通路技术的血管疗法公司的收购，以增强其外周介入业务。
- **2024年第二季度：Ra Medical Systems宣布与MedAlliance建立战略合作伙伴关系，进行切除设备分销** Ra Medical Systems与MedAlliance建立战略合作伙伴关系，在特定国际市场分销其切除设备，旨在扩大全球影响力。
- **2024年第三季度：Avinger宣布商业推出Tigereye ST影像引导CTO穿刺导管** Avinger在美国市场推出其Tigereye ST影像引导慢性完全闭塞（CTO）穿刺导管，扩展其切除和穿刺设备系列。
- **2024年第二季度：Cardio Flow, Inc.获得FDA对FreedomFlow®轨道切除系统市场的批准** Cardio Flow, Inc.获得FDA批准，推出其FreedomFlow®轨道切除系统市场，旨在治疗下肢的外周动脉疾病。
- **2024年第一季度：Shockwave Medical宣布获得FDA对Shockwave M5+外周IVL导管的批准** Shockwave Medical获得FDA批准，推出其Shockwave M5+外周IVL导管，该导管结合了血管内碎石术和切除术，用于治疗钙化的外周动脉疾病。
- **2024年第二季度：美敦力在爱尔兰戈尔韦开设新的外周血管设备制造设施** 美敦力在爱尔兰戈尔韦开设新的制造设施，专注于生产外周血管设备，包括切除系统，以满足日益增长的全球需求。
- **2024年第三季度：Avinger宣布进行1500万美元的公开募股，以支持切除产品开发** Avinger完成了一项1500万美元的公开募股，以资助其下一代影像引导切除设备的开发和商业化。
- **2024年第二季度：飞利浦与梅奥诊所合作推进切除设备研究** 飞利浦与梅奥诊所建立研究合作伙伴关系，开发和临床验证用于治疗复杂血管疾病的新切除技术。

## 切除系统市场细分洞察

### 切除系统市场程序类型展望

- 外周切除
- 冠状动脉切除
- 脑切除

### 切除系统市场设备类型展望

-   - 旋转切除设备 - 方向性切除设备 - 轨道切除设备

### 切除系统市场最终用户展望

- 医院
- 专科诊所
- 门诊手术中心
- **切除系统市场应用展望** - 冠状动脉疾病 - 外周动脉疾病 - 脑血管疾病

### **切除系统市场区域展望**

- 北美
- 欧洲
- 南美
- 亚太地区
- 中东和非洲

## Report Scope

| 2024年市场规模 | 1.756（十亿美元） |
| --- | --- |
| 2025年市场规模 | 1.847（十亿美元） |
| 2035年市场规模 | 3.055（十亿美元） |
| 复合年增长率（CAGR） | 5.16%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 微创技术的进步增强了动脉切除系统市场的增长潜力。 |
| 主要市场动态 | 技术进步和监管变化推动动脉切除系统市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，动脉切除系统市场的预计市场估值是多少？**
A: 动脉切除系统市场预计到2035年将达到30.55亿美元的估值。

**Q: 2024年动脉切除系统市场的市场估值是多少？**
A: 2024年，动脉切除系统市场的价值为17.56亿美元。

**Q: 在2025年至2035年的预测期内，动脉切除系统市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，动脉切除系统市场的预期CAGR为5.16%。

**Q: 在动脉切除系统市场中，哪些公司被视为关键参与者？**
A: 在动脉切除系统市场中的主要参与者包括波士顿科学公司、美敦力、雅培实验室和心血管系统公司。

**Q: 根据手术类型，动脉切除系统市场的主要细分领域是什么？**
A: 主要的程序类型包括外周动脉切除术、冠状动脉切除术和脑动脉切除术。

**Q: 到2035年，外周动脉切除术的预计估值是多少？**
A: 预计外周动脉切除术的估值到2035年将达到12亿美元。

**Q: 方向性动脉粥样硬化切除装置的市场与旋转动脉粥样硬化切除装置相比如何？**
A: 到2035年，方向性动脉切除装置的市场预计将达到8.83亿美元，而旋转动脉切除装置的市场可能达到11.95亿美元。

**Q: 到2035年，作为动脉切除系统最终用户的医院预期市场规模是多少？**
A: 预计到2035年，作为动脉切除系统最终用户的医院市场规模将达到14.82亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/atherectomy-system-market-34266*